lung cancer bronchoscope marking
Conditions
Interventions
Off-label use of indocyanine green with indigo carmine for bronchoscope marking before surgery of lung cancer
indocyanine green
Sponsors
Sato Masaaki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) With suspected or diagnosed lung cancer, who require lung resection other than standard lobectomy (2) With lesions which are predicted to be difficult to identify and require careful determination of resection lines to obtain sufficient resection margins in surgery: A) Difficult to identify due to the characteristics of the lesions B) Difficult to identify due to the condition of the lung C) Judged to need lung mapping by clinical investigators due to other reasons (3) Aged 18 years and above at the time of informed consent is taken (4) Male or female (5) Able and willing to give written informed consent with sufficient understanding after having received sufficient explanation
Exclusion criteria
Exclusion criteria: (1) With allergy to iodine contrast (2) Having a history of asthma (3) Having a history of allergy to indocyanine green or indigo carmine (4) Having a history of severe drug allergy or severe side effects (5) Judged as ineligible by clinical investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of successful markings | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Rate of successful resections (2) Incidence of perioperative complications (3) Incidence of adverse events | — |
Contacts
Public ContactMasaaki Nagano
The University of Tokyo Hospital
Outcome results
None listed